Approval Year
| Substance Class |
Mixture
Created
by
admin
on
Edited
Tue Apr 01 22:32:13 GMT 2025
by
admin
on
Tue Apr 01 22:32:13 GMT 2025
|
| Record UNII |
3N9MP29ETS
|
| Record Status |
FAILED
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
67153945
Created by
admin on Tue Apr 01 22:32:13 GMT 2025 , Edited by admin on Tue Apr 01 22:32:13 GMT 2025
|
PRIMARY | |||
|
1298086-28-8
Created by
admin on Tue Apr 01 22:32:13 GMT 2025 , Edited by admin on Tue Apr 01 22:32:13 GMT 2025
|
PRIMARY | |||
|
3N9MP29ETS
Created by
admin on Tue Apr 01 22:32:13 GMT 2025 , Edited by admin on Tue Apr 01 22:32:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> METABOLITE |
(PLASMA CIRCULATION) 2.5%, (URINE) 0.7%, (FECES) 1.7%, AFTER ADMINISTRATION OF A SINGLE 25-MG (100 MICROCURIE) ORAL DOSE OF (14C)-ERTUGLIFLOZIN (N=6, ALL MALE)
IN-VIVO
FECAL; PLASMA; URINE
|